Ann: Investor Presentation, page-5

Not actually sure I follow, nothing new in that list just regurgitated and extended dates.

The only glimmer of hope I sew in the release is on slide 15 which eludes to the facts that:

1. Monash successfully isolated the various fractions responsible…….
2. An agreement was reached for The Doherty Institute to test those fractions efficacy and of startling news it commenced in Dec 21.
3. Finally, draft protocols in development to expand that work.

The above is of great importance, and correct me if I’m wrong, but I do not recall seeing a single release advising of point 2 above. A point that I, a reasonable person would expect that such news may have an effect on the share price.
(I admit IMC has become a bit of a bottom draw follow for me recently, IMC is living proof that you can’t teach an old dog new tricks. They have no interest in building holder wealth through self driven hard work or self promotion, IMC are happy to allow others to do the grunt work, so to speak, whilst slowly siphoning off the cash for the board/exec. “Lifestyler”)

Sadly, my last remaining hope for IMC is that they stumble upon some momentous breakthrough. My confidence in their capability of steering themselves towards that momentous breakthrough has gone.